Directive 93/41/EEC

---

title: "Directive 93/41/EEC" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["health-and-the-european-union", "pharmaceuticals-policy", "european-union-directives", "european-union-directives-by-number", "1993-in-law", "1993-in-the-european-union"] description: "European Union Directive (EU) 1993/41" topic_path: "law" source: "https://en.wikipedia.org/wiki/Directive_93/41/EEC" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary European Union Directive (EU) 1993/41 ::

Council of the European Communities Directive 93/41/EEC of 14 June 1993 repealed Directive 87/22/EEC on the approximation of national measures relating to the marketing of high-technology medicinal products, as this directive had been superseded by Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products (5) and by Council Directive 88/182/EEC of 22 March 1988 amending Directive 83/189/EEC laying down a procedure for the provision of information in the field of technical standards and regulations (6).

References

• Council Directive 93/41/EEC of 14 June 1993 repealing Directive 87/22/EEC

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::